Oral contraceptives and reproductive factors in multiple sclerosis incidence

Villard-Mackintosh L; Vessey MP

doi:10.1016/0010-7824(93)90088-o

Contraception Oral Contraceptives

Oral contraceptives and reproductive factors in multiple sclerosis incidence

Villard-Mackintosh L, Vessey MP

Published February 1993 Contraception, 47(2), 161-168

DOI 10.1016/0010-7824(93)90088-o PMID 8449016

Abstract

Data from the Oxford.FPA prospective study show that oral contraceptive use and pregnancy have no discernible effect on the risk of developing multiple sclerosis (MS). Women of parity 0-2 developed MS twice as often as women of parity 3 or more but the difference did not reach statistical significance. Smoking may be a risk factor for developing MS. A nested case-control analysis did not identify any associations between MS onset and preceding illnesses.

Topics

Contraception

Oral Contraceptives Autoimmune Disease Risk

Contraception › Oral Contraceptives › Autoimmune Disease Risk

PMID 8449016 8449016 DOI 10.1016/0010-7824(93)90088-o 10.1016/0010-7824(93)90088-o Villard-Mackintosh et al. 1993, Villard-Mackintosh 1993

Keywords

Contraceptives, Oral

Oral contraceptives and reproductive factors in multiple sclerosis incidence

Abstract

Topics

By this author

Related research

Keywords